GL1X · GenesisL1 explorer

Research workbench

Crystal structure of BCL-xl in complex with inhibitor (wehi-539)

Analyse Crystal structure of BCL-xl in complex with inhibitor (wehi-539) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ZLR
Type
protein
Length
290 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
BCL-2-like protein 1
UniProt
Q07817
Ligands
X0B, SO4
Pockets
3 · best druggability 0.61

Structure

x-ray diffraction · 2 distinct chains · 74% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABCL-2-like protein 1protein14677% helix, 0% strandQ07817
BBCL-2-like protein 1protein14472% helix, 0% strandQ07817

Ligands and binding sites

  • X0B · 5-[3-[4-(aminomethyl)phenoxy]propyl]-2-[(8E)-8-(1,3-benzothiazol-2-ylhydrazinylidene)-6,7-dihydro-5H-naphthalen-2-yl]-1,3-thiazole-4-carboxylic acid · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 3 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12630.610.8036empty
21730.550.8025X0B
31410.500.7918X0B

Interfaces

1 interface between chains.

  • A–B · 2155 Ų buried · 26 hydrogen bonds · protein-protein

Compared structures

  • 3ZLR · Crystal structure of BCL-XL in complex with inhibitor (WEHI-539) · the same entry in another collection · chain A against A, TM-score 1.00
  • Q07817 · AlphaFold monomer V2.0 prediction for BCL-2-like protein 1 (Q07817) · a predicted model of the same protein · chain B against A, TM-score 0.74

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.